melatonin has been researched along with Peripheral Nerve Diseases in 10 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Melatonin treatment reversed the I/R-induced increase and decrease in MDA and SOD levels, respectively." | 5.32 | Beneficial effects of melatonin on reperfusion injury in rat sciatic nerve. ( Aktas, RG; Arslan, SO; Coskun, O; Ozacmak, VH; Ozen, OA; Sayan, H; Sezen, SC, 2004) |
| "The thermal nociceptive/hyperalgesia tests were performed." | 1.72 | The Combination of Zinc and Melatonin Enhanced Neuroprotection and Attenuated Neuropathy in Oxaliplatin-Induced Neurotoxicity. ( Ali, M; Aziz, T, 2022) |
| "Melatonin treatment significantly alleviated oxaliplatin-induced pain behavior and neuropathic deficits in rats." | 1.46 | Melatonin prevents mitochondrial dysfunction and promotes neuroprotection by inducing autophagy during oxaliplatin-evoked peripheral neuropathy. ( Akuthota, M; Areti, A; Komirishetty, P; Kumar, A; Malik, RA, 2017) |
| "Melatonin treatments increased the SFI values in the injured sciatic nerves." | 1.36 | Electrophysiological and theoretical analysis of melatonin in peripheral nerve crush injury. ( Bilgin, MD; Yaraneri, H; Zencirci, SG, 2010) |
| "Here we report that both mechanical allodynia and depression-like behavior were significantly exacerbated after peripheral nerve injury in Wistar-Kyoto (WKY) rats, a genetic variation of Wistar rats with demonstrable depression-like behavior." | 1.35 | Exacerbated mechanical allodynia in rats with depression-like behavior. ( Chang, Y; Guo, G; Lim, G; Lim, JA; Mao, J; Sung, B; Wang, S; Yang, L; Zeng, Q, 2008) |
| "Melatonin treatment reversed the I/R-induced increase and decrease in MDA and SOD levels, respectively." | 1.32 | Beneficial effects of melatonin on reperfusion injury in rat sciatic nerve. ( Aktas, RG; Arslan, SO; Coskun, O; Ozacmak, VH; Ozen, OA; Sayan, H; Sezen, SC, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (10.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (30.00) | 29.6817 |
| 2010's | 4 (40.00) | 24.3611 |
| 2020's | 2 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ali, M | 1 |
| Aziz, T | 1 |
| Soliman, A | 1 |
| Wahid, A | 1 |
| Wahby, MM | 1 |
| Bassiouny, A | 1 |
| Keskin, I | 1 |
| Kaplan, S | 1 |
| Kalkan, S | 1 |
| Sutcu, M | 1 |
| Ulkay, MB | 1 |
| Esener, OB | 1 |
| Areti, A | 1 |
| Komirishetty, P | 1 |
| Akuthota, M | 1 |
| Malik, RA | 1 |
| Kumar, A | 1 |
| Lin, AM | 1 |
| Feng, SF | 1 |
| Chao, PL | 1 |
| Yang, CH | 1 |
| Zencirci, SG | 1 |
| Bilgin, MD | 1 |
| Yaraneri, H | 1 |
| Tuncer, S | 1 |
| Dalkilic, N | 1 |
| Akif Dunbar, M | 1 |
| Keles, B | 1 |
| Sayan, H | 1 |
| Ozacmak, VH | 1 |
| Ozen, OA | 1 |
| Coskun, O | 1 |
| Arslan, SO | 1 |
| Sezen, SC | 1 |
| Aktas, RG | 1 |
| Zeng, Q | 1 |
| Wang, S | 1 |
| Lim, G | 1 |
| Yang, L | 1 |
| Mao, J | 2 |
| Sung, B | 1 |
| Chang, Y | 1 |
| Lim, JA | 1 |
| Guo, G | 1 |
| Higa, S | 1 |
| Suzuki, T | 1 |
| Sakoda, S | 1 |
| Kishimoto, S | 1 |
| Takaba, Y | 1 |
| Nakajima, A | 1 |
| Markey, SP | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Effects of Oral Melatonin on Neurosensory Recovery Following Facial Osteotomies - A Randomised, Controlled Clinical Trial[NCT02889432] | Phase 2 | 40 participants (Anticipated) | Interventional | 2016-06-30 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
10 other studies available for melatonin and Peripheral Nerve Diseases
| Article | Year |
|---|---|
The Combination of Zinc and Melatonin Enhanced Neuroprotection and Attenuated Neuropathy in Oxaliplatin-Induced Neurotoxicity.
Topics: Animals; Antioxidants; Hyperalgesia; Male; Melatonin; Neural Cell Adhesion Molecules; Neuroprotectio | 2022 |
Study of the possible synergistic protective effects of Melatonin and Pregabalin in Vincristine induced peripheral neuropathy Wistar Albino rats.
Topics: Animals; Anticonvulsants; Antineoplastic Agents, Phytogenic; Antioxidants; Drug Synergism; Male; Mel | 2020 |
Evaluation of neuroprotection by melatonin against adverse effects of prenatal exposure to a nonsteroidal anti-inflammatory drug during peripheral nerve development.
Topics: Age Factors; Analysis of Variance; Animals; Animals, Newborn; Anti-Inflammatory Agents, Non-Steroida | 2015 |
Melatonin prevents mitochondrial dysfunction and promotes neuroprotection by inducing autophagy during oxaliplatin-evoked peripheral neuropathy.
Topics: Autophagy; Cell Line, Tumor; Humans; Melatonin; Membrane Potential, Mitochondrial; Microtubule-Assoc | 2017 |
Melatonin inhibits arsenite-induced peripheral neurotoxicity.
Topics: Analysis of Variance; Animals; Arsenites; Ganglia, Spinal; Heat-Shock Proteins; Heme Oxygenase-1; HS | 2009 |
Electrophysiological and theoretical analysis of melatonin in peripheral nerve crush injury.
Topics: Animals; Disease Models, Animal; Male; Melatonin; Nerve Regeneration; Neuroprotective Agents; Periph | 2010 |
Comparative effects of α lipoic acid and melatonin on cisplatin-induced neurotoxicity.
Topics: Animals; Antineoplastic Agents; Antioxidants; Cisplatin; Male; Melatonin; Peripheral Nervous System | 2010 |
Beneficial effects of melatonin on reperfusion injury in rat sciatic nerve.
Topics: Animals; Axons; Cytoprotection; Lipid Peroxidation; Male; Malondialdehyde; Melatonin; Myelin Sheath; | 2004 |
Exacerbated mechanical allodynia in rats with depression-like behavior.
Topics: Animals; Depressive Disorder; Disease Models, Animal; Genetic Predisposition to Disease; Gyrus Cingu | 2008 |
Disturbed function of the pineal gland in familial amyloid polyneuropathy.
Topics: Adrenal Medulla; Adult; Amyloidosis; Female; Humans; Male; Melatonin; Metanephrine; Middle Aged; Nor | 1987 |